Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
The results of SURPASS-6 further support the role of Tirzepatide in treatment of individuals with type 2 on insulin and obesity. The primary goal of the trial was to determine if tirzepatide was as safe and effective as fast-acting insulin in lowering A1C over 52 weeks
CrossRef Non-Alcoholic Fatty Liver Disease, Awareness of a Diagnostic ChallengeA Clinicians Perspective Cristina Maria Marginean, Denisa Pirscoveanu, Sergiu Marian Cazacu, Marian Sorin Popescu, Iulia Cristina Marginean, George Alexandru Iacob, Mihaela Popescu Gastroenterology Insights .2024
2017;49(10):e12768.
Cost by dosage: how your dose affects what you pay Not all providers price tirzepatide the same way
US$ 27.08
US$ 23.40
US$ 21.73
US$ 20.33
US$ 28.64
US$ 29.80
US$ 28.64
US$ 27.99
US$ 23.09
